(Q51483465)

5 April 2018

title

Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. (English)

1 reference

5 April 2018

1 reference

1 reference

Heiskanen T

1

1 reference

5 April 2018

Olkkola KT

series ordinal

2

1 reference

5 April 2018

Kalso E

series ordinal

3

1 reference

5 April 2018

language of work or name

English

0 references

publication date

1 December 1998

1 reference

5 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

5 April 2018

volume

64

1 reference

5 April 2018

issue

6

1 reference

5 April 2018

page(s)

603-611

1 reference

5 April 2018

Determination of oxycodone metabolites in urines and feces of several mammalian species

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

The pharmacokinetics of oxycodone after intravenous injection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Pencil and paper tests-sensitivity to psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Patient-controlled analgesia (PCA) with codeine for postoperative pain relief in ten extensive metabolisers and one poor metaboliser of dextromethorphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Morphine and oxycodone hydrochloride in the management of cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Intravenous morphine and oxycodone for pain after abdominal surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Dose-ranging study of oxycodone for chronic pain in advanced cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Mu receptor binding of some commonly used opioids and their metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Determination of Oxycodone in Plasma and Identification of a Major Metabolite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

The antinociceptive potencies of oxycodone, noroxycodone and morphine after intracerebroventricular administration to rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Controlled-release oxycodone and morphine in cancer related pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Comparison of epidural morphine and oxycodone for pain after abdominal surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Antinociceptive effects and central nervous system depression caused by oxycodone and morphine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Single-dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Extensive metabolizers of debrisoquine become poor metabolizers during quinidine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Abuse potential and pharmacological comparison of tramadol and morphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Measurement of Recovery from Outpatient General Anaesthesia with a Simple Ocular Test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects?A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Lack of relationship between quinidine pharmacokinetics and the sparteine oxidation polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Characterization and validation of a pharmacokinetic model for controlled-release oxycodone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

A pharmacokinetic/pharmacodynamic study of controlled-release oxycodone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Psychomotor, respiratory and neuroendocrinological effects of buprenorphine and amitriptyline in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Dextromethorphan: enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Polymorphic O-demethylation of codeine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990051-0

10.1016/S0009-9236(98)90051-0

7 January 2021

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018